Emergent BioSolutions completed the repurchase of $75 million aggregate principal amount of senior unsecured notes.
Published
Signal category
Capital & Finance
Quote
“Today Emergent announced that it has completed the repurchase of $75 million aggregate principal amount of senior unsecured notes.”
— Emergent BioSolutions team
Company
Emergent BioSolutions
We help prepare for today's challenges and tomorrow's threats.
- Industry
- Biotechnology Research
- Location
- Gaithersburg, US
- Company size
- 1,366 employees
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify. Please note: It has come to our attention that there may be people posing as Emergent recruiters and hiring managers online, offering fraudulent opportunities to job seekers. Emergent will never ask for any financial commitment from a candidate as a pre-employment requirement. Learn more about recruitment fraud and how to protect yourself here: https://bit.ly/recruitment-fraud
Founded 1998